Cetera Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
$5.82M Buy
13,912
+5,390
+63% +$2.25M 0.05% 407
2023
Q4
$3.47M Buy
8,522
+1,568
+23% +$638K 0.05% 359
2023
Q3
$2.42M Sell
6,954
-201
-3% -$69.9K 0.04% 404
2023
Q2
$2.52M Buy
7,155
+212
+3% +$74.6K 0.04% 398
2023
Q1
$2.19M Sell
6,943
-2,076
-23% -$654K 0.04% 416
2022
Q4
$2.6M Buy
9,019
+1,010
+13% +$292K 0.05% 380
2022
Q3
$2.32M Buy
8,009
+2,985
+59% +$864K 0.06% 327
2022
Q2
$1.42M Sell
5,024
-287
-5% -$80.9K 0.03% 474
2022
Q1
$1.39M Buy
5,311
+95
+2% +$24.8K 0.03% 505
2021
Q4
$1.15M Sell
5,216
-12,737
-71% -$2.8M 0.02% 554
2021
Q3
$3.26M Sell
17,953
-10,104
-36% -$1.83M 0.06% 296
2021
Q2
$5.66M Buy
28,057
+23,172
+474% +$4.67M 0.13% 162
2021
Q1
$1.05M Buy
4,885
+42
+0.9% +$9.03K 0.03% 464
2020
Q4
$1.15M Buy
4,843
+642
+15% +$152K 0.04% 386
2020
Q3
$1.14M Sell
4,201
-15
-0.4% -$4.08K 0.04% 351
2020
Q2
$1.22M Buy
4,216
+1,678
+66% +$487K 0.05% 317
2020
Q1
$604K Buy
2,538
+92
+4% +$21.9K 0.03% 422
2019
Q4
$533K Buy
2,446
+18
+0.7% +$3.92K 0.02% 545
2019
Q3
$412K Buy
2,428
+8
+0.3% +$1.36K 0.02% 603
2019
Q2
$445K Sell
2,420
-91
-4% -$16.7K 0.02% 594
2019
Q1
$462K Buy
2,511
+119
+5% +$21.9K 0.02% 516
2018
Q4
$397K Sell
2,392
-1,430
-37% -$237K 0.02% 542
2018
Q3
$739K Buy
3,822
+641
+20% +$124K 0.04% 438
2018
Q2
$541K Buy
3,181
+4
+0.1% +$680 0.03% 489
2018
Q1
$517K Buy
+3,177
New +$517K 0.03% 464